Latest Biotech News

Scientists have uncovered enzymes and microbial functions with implications for environmental sustainability and biotechnology. Researchers at Leiden identified a common enzyme aiding bacterial...

The pharmaceutical industry is grappling with regulatory and market complexities. Lawsuits accusing generic drugmakers of price fixing have escalated, with Southwest Airlines filing suit for...

Biotech and pharmaceutical companies have entered several strategic partnerships and expansion initiatives. HeartBeat Bio and BiotxAI formed a collaboration to discover and validate genomic...

Merck announced a $10 billion acquisition of Verona Pharma to enhance its respiratory disease portfolio, focusing on chronic obstructive pulmonary disease (COPD). The deal includes the recently...

KalVista Pharmaceuticals won FDA approval for Ekterly (sebetralstat), the first oral on-demand therapy for hereditary angioedema (HAE) attacks in patients aged 12 and older. The approval follows a...

ProKidney’s rilparencel, a cell therapy for chronic kidney disease (CKD), presented mixed findings in a phase 2 trial. One cohort receiving two injections demonstrated a significant 78% slowing in...

Cogent Biosciences reported positive phase 2 results for bezuclastinib, targeting non-advanced systemic mastocytosis. The drug achieved statistically significant improvements in symptom scores and...

Revolution Medicines and Iambic Therapeutics have partnered in a multi-year collaboration to harness AI technology for cancer drug discovery. Iambic will train its NeuralPLexer AI model using...

A recent trial in China demonstrated promising results for AAV-OTOF gene therapy in treating autosomal recessive deafness 9. Ten participants aged 1.5 to 23.9 years showed significant hearing...

Cytiva disclosed plans to complete $1.6 billion in expansions across the US, Europe, and Asia, to meet rising demand for biopharma manufacturing capabilities and promote in-region production....

FDA efforts to reduce animal testing were reaffirmed by Commissioner Marty Makary, emphasizing streamlined drug development. Meanwhile, a federal lawsuit challenges recent federal changes to...

Emerging studies reveal advances in RNA therapeutics and protein degraders, with AI-driven methods spotlighting novel targets and improving treatment efficacy. A machine learning approach now...

Actithera, a pioneering radiopharmaceutical biotech based in Oslo and Cambridge, secured nearly $76 million in Series A financing to progress its novel cancer therapy pipeline targeting fibroblast...

KalVista Pharmaceuticals won FDA accelerated approval for Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema (HAE) in patients aged 12 and older. The approval...

Cogent Biosciences’ bezuclastinib demonstrated statistically significant improvements in indolent systemic mastocytosis during a registrational Phase II study, producing meaningful symptomatic...

ProKidney’s autologous cell therapy rilparencel reported a 78% slowing of kidney function decline in one patient cohort of a Phase II chronic kidney disease trial, while a second cohort showed a...

Novartis gained Swiss regulatory clearance for Coartem Baby, the first malaria treatment formulated specifically for newborns and young infants. The new dosing addresses an unmet need for safe,...

Researchers have developed new AI-driven techniques to rapidly engineer proteins by integrating structural and evolutionary constraints without custom training for specific proteins. Additionally,...

The FDA is experiencing a significant morale and staffing crisis following major personnel departures in April and ongoing talent losses. This exodus threatens the agency’s capacity to maintain...

Collaborations and clinical advances mark progress in gene editing and therapeutic development. Abu Dhabi’s DoH joined forces with UCSF and Innovative Genomics Institute to establish genome...